Clinical Trial Update: Effect of a New High-protein Oral Supplement on Functional Parameters in Patients in Nursing Homes [Phase 2]

View source ↗

Summary

Phase 2 trial by Lactalis evaluating a new high-protein oral supplement on functional parameters in malnourished nursing home patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malnutrition

Drugs mentioned

• High-protein oral supplement

Snippet

Sponsor: Lactalis | Conditions: Malnutrition | Phase 2 | Status: COMPLETED